2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Long-term oncological outcomes after laparoscopic parenchyma-sparing redo liver resections for patients with metastatic colorectal cancer: a European multi-center study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Laparoscopic redo resections for colorectal metastases are poorly investigated. This study aims to explore long-term results after second, third, and fourth resections.

          Material and methods

          Prospectively updated databases of primary and redo laparoscopic liver resections in six European HPB centers were analyzed. Procedure-related overall survival after first, second, third, and fourth resections were evaluated. Furthermore, patients without liver recurrence after first liver resection were compared to those with one redo, two or three redo, and patients with palliative treatment for liver recurrence after first laparoscopic liver surgery. Survival was calculated both from the date of the first liver resection and from the date of the actual liver resection. In total, 837 laparoscopic primary and redo liver resections performed in 762 patients were included (630 primary, 172 first redo, 29 second redo, and 6 third redo). Patients were bunched into four groups: Group 1—without hepatic recurrence after primary liver resection ( n = 441); Group 2—with liver recurrence who underwent only one laparoscopic redo resection ( n = 154); Group 3—with liver recurrence who underwent two laparoscopic redo resections ( n = 29); Group 4—with liver recurrence who have not been found suitable for redo resections ( n = 138).

          Results

          No significant difference has been found between the groups in terms of baseline characteristics and surgical outcomes. Rate of positive resection margin was higher in the group with palliative recurrence (group 4). Five-year survival calculated from the first liver resection was 67%, 62%, 84%, and 7% for group 1, 2, 3, and 4, respectively. Procedure-specific 5-year overall survival was 50% after primary laparoscopic liver resection, 52% after the 1st reoperation, 52% after the 2nd, and 40% after the 3rd reoperation made laparoscopic.

          Conclusions

          Multiple redo recurrences can be performed laparoscopically with good long-term results. Liver recurrence does not aggravate prognosis as long as the patient is suitable for reoperation.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          Laparoscopic Versus Open Resection for Colorectal Liver Metastases

          To perform the first randomized controlled trial to compare laparoscopic and open liver resection.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Comparative Short-term Benefits of Laparoscopic Liver Resection: 9000 Cases and Climbing.

            To perform a systematic review of worldwide literature on laparoscopic liver resections (LLR) and compare short-term outcomes against open liver resections (OLR) by meta-analyses.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors

              Background Hepatic metastases develop in approximately 50% of colorectal cancer (CRC) cases. We performed a review and meta-analysis to evaluate survival after resection of CRC liver metastases (CLMs) and estimated the summary effect for seven prognostic factors. Methods Studies published between 1999 and 2010, indexed on Medline, that reported survival after resection of CLMs, were reviewed. Meta-relative risks for survival by prognostic factor were calculated, stratified by study size and annual clinic volume. Cumulative meta-analysis results by annual clinic volume were plotted. Results Five- and 10-year survival ranged from 16% to 74% (median 38%) and 9% to 69% (median 26%), respectively, based on 60 studies. The overall summary median survival time was 3.6 (range: 1.7–7.3) years. Meta-relative risks (95% confidence intervals) by prognostic factor were: node positive primary, 1.6 (1.5–1.7); carcinoembryonic antigen level, 1.9 (1.1–3.2); extrahepatic disease, 1.9 (1.5–2.4); poor tumor grade, 1.9 (1.3–2.7); positive margin, 2.0 (1.7–2.5); >1 liver metastases, 1.6 (1.4–1.8); and >3 cm tumor diameter, 1.5 (1.3–1.8). Cumulative meta-analyses by annual clinic volume suggested improved survival with increasing volume. Conclusion The overall median survival following CLM liver resection was 3.6 years. All seven investigated prognostic factors showed a modest but significant predictive relationship with survival, and certain prognostic factors may prove useful in determining optimal therapeutic options. Due to the increasing complexity of surgical interventions for CLM and the inclusion of patients with higher disease burdens, future studies should consider the potential for selection and referral bias on survival.
                Bookmark

                Author and article information

                Contributors
                leonid.barkhatov@gmail.com
                Journal
                Surg Endosc
                Surg Endosc
                Surgical Endoscopy
                Springer US (New York )
                0930-2794
                1432-2218
                30 August 2021
                30 August 2021
                2022
                : 36
                : 5
                : 3374-3381
                Affiliations
                [1 ]GRID grid.55325.34, ISNI 0000 0004 0389 8485, The Intervention Centre, , Oslo University Hospital, ; Rikshospitalet, Norway
                [2 ]GRID grid.412008.f, ISNI 0000 0000 9753 1393, Department of Acute and Digestive Surgery, , Haukeland University Hospital, ; Bergen, Norway
                [3 ]GRID grid.5510.1, ISNI 0000 0004 1936 8921, Institute of Clinical Medicine, , Oslo University, ; Rikshospitalet, Norway
                [4 ]Department of General Surgery, Pellegrini Hospital, Naples, Italy
                [5 ]GRID grid.18887.3e, ISNI 0000000417581884, Hepatobiliary Surgery Division, , IRCCS San Raffaele Scientific Institute, ; Milan, Italy
                [6 ]GRID grid.55325.34, ISNI 0000 0004 0389 8485, Department of Hepatic, Pancreatic and Biliary Surgery, , Oslo University Hospital, ; Rikshospitalet, Norway
                [7 ]GRID grid.412938.5, ISNI 0000 0004 0627 3923, Department of Digestive Surgery, , Østfold Hospital Trust, ; Grålum, Norway
                [8 ]GRID grid.413738.a, ISNI 0000 0000 9454 4367, Department of Minimally Invasive Digestive Surgery, , Antoine-Beclere Hospital, Assistance Publique - Hôpitaux de Paris, ; Clamart, France
                [9 ]GRID grid.460789.4, ISNI 0000 0004 4910 6535, Paris-Saclay University, ; Orsay, France
                [10 ]Department of General and HPB Surgery, S.M. Loreto Nuovo Hospital, Naples, Italy
                [11 ]GRID grid.123047.3, ISNI 0000000103590315, Department of Surgery, , Southampton University Hospital NHS Foundation Trust, ; Southampton, UK
                [12 ]GRID grid.411293.c, ISNI 0000 0004 1754 9702, Division of HPB, Department of Clinical Medicine and Surgery, , Minimally Invasive and Robotic Surgery, Federico II University Hospital, ; Naples, Italy
                [13 ]GRID grid.15496.3f, ISNI 0000 0001 0439 0892, Vita-Salute San Raffaele University, ; Milan, Italy
                [14 ]GRID grid.415090.9, ISNI 0000 0004 1763 5424, Department of Surgery, , Fondazione Poliambulanza - Instituto Ospedaliero, ; Brescia, Italy
                [15 ]GRID grid.508451.d, ISNI 0000 0004 1760 8805, Department of Abdominal Oncology, , HPB Surgical Oncology Unit, National Cancer Institute, Fondazione G. Pascale - IRCCS, ; Naples, Italy
                Author information
                http://orcid.org/0000-0003-1126-3052
                Article
                8655
                10.1007/s00464-021-08655-z
                9001231
                34462867
                088b5dd0-cb7c-4e0e-92d9-bd823c93c0a3
                © The Author(s) 2021

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 12 January 2021
                : 16 July 2021
                Funding
                Funded by: University of Oslo (incl Oslo University Hospital)
                Categories
                Article
                Custom metadata
                © Springer Science+Business Media, LLC, part of Springer Nature 2022

                Surgery
                laparoscopic liver surgery,redo liver resections,colorectal liver metastases,parenchyma-sparing liver resections

                Comments

                Comment on this article